Table 3.

Time to prescription of targeted therapies for non-small cell lung cancer treatment over time (2004–2013)

	Time to prescription (days)
	Targeted therapies (gefitinib+erlotinib)		Gefitinib		Erlotinib
	Mean	SD	Mean	SD	Mean	SD
2004	801.7	654.6	685.3	587.4	1602.0	520.7
2005	683.4	546.2	570.0	497.4	1128.7	500.4
2006	603.0	471.2	522.1	440.9	743.2	489.4
2007	457.6	397.7	402.4	394.6	524.2	391.4
2008	383.0	343.7	390.1	379.9	377.6	313.1
2009	369.3	315.7	382.1	340.7	359.2	294.2
2010	329.8	242.9	325.6	247.7	333.4	238.8
2011	207.2	207.0	137.9	182.4	313.5	197.2
2012	120.3	137.4	68.5	104.3	249.1	124.7
2013	43.0	49.6	32.5	33.7	128.9	70.8